-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Cytek Biosciences Partners With Bio-Rad To Expand Reagent Portfolios; Under Terms Include, Bio-Rad's High-Performing New Starbright Dyes Will Be Available To Cytek To Develop And Commercialize Reagent Products To Support High-Parameter Application
Cytek Biosciences Partners With Bio-Rad To Expand Reagent Portfolios; Under Terms Include, Bio-Rad's High-Performing New Starbright Dyes Will Be Available To Cytek To Develop And Commercialize Reagent Products To Support High-Parameter Application
Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (NASDAQ:CTKB) today announced that it has entered into a strategic partnership with leading life science research and clinical diagnostics products company Bio-Rad Laboratories, Inc. (NYSE:BIO). Under the terms of the agreement, Bio-Rad's exceptionally bright, high-performing new StarBright Dyes will be available to Cytek to develop and commercialize reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems.
Bio-Rad's StarBright Dyes have been designed to be stable with superior brightness, narrow excitation and emission characteristics for minimized spillover and improved resolution of specific cell populations, allowing researchers to build bigger, better panels.
Bio-Rad's StarBright Dyes complement Cytek's cFluor family of proprietary dyes, providing a wider variety of color options for highly multiplexed panel design and application development. Cytek plans to develop and optimize single vial reagents and multicolor panels using StarBright Dyes for the more than 1,500 Cytek Full Spectrum Profiling (FSP) instruments already deployed across more than 40 countries.
"Our focus has always been to provide a complete cell analysis solution to our customers, and the addition of Bio-Rad StarBright Dyes to our FSP platform is a big win for researchers conducting multiparameter experiments," noted Wenbin Jiang, CEO of Cytek Biosciences. "Researchers will be able to expand multiparameter analysis into violet and UV channels with Cytek-optimized reagents, unleashing the full power of FSP technology to obtain better resolution and a deeper understanding of populations."
Bio-Rad StarBright Dye conjugates can also be integrated seamlessly into Cytek immunoprofiling assays. These easy-to-use, pre-optimized panels are designed by Cytek's scientists, freeing researchers from time-consuming, labor-intensive and costly panel design and optimization.
"Cytek has made a name for itself as a pioneer that has shifted the conventional dynamics surrounding flow cytometry, making our unique new reagents a perfect fit for their instruments," said Hilary Latham, marketing director for Bio-Rad. "We are proud to team with Cytek to bring more high-quality reagent choices on both violet and UV channels to researchers."
For more information about Cytek's cFluor reagents and kits, please visit
Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (NASDAQ:CTKB) today announced that it has entered into a strategic partnership with leading life science research and clinical diagnostics products company Bio-Rad Laboratories, Inc. (NYSE:BIO). Under the terms of the agreement, Bio-Rad's exceptionally bright, high-performing new StarBright Dyes will be available to Cytek to develop and commercialize reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems.
为促进免疫肿瘤学和免疫疗法研究人员的发展,赛特克生物科学公司(纳斯达克代码:CTKB)今天宣布,它已经与领先的生命科学研究和临床诊断产品公司Bio-Rad实验室公司(纽约证券交易所代码:BIO)建立了战略合作伙伴关系。根据协议条款,Cytek将可使用Bio-Rad异常明亮、高性能的新型Starbright染料,以开发试剂产品并将其商业化,以支持Aurora和Northern Lights流式细胞仪系统的高参数应用。
Bio-Rad's StarBright Dyes have been designed to be stable with superior brightness, narrow excitation and emission characteristics for minimized spillover and improved resolution of specific cell populations, allowing researchers to build bigger, better panels.
Bio-Rad的Starbright染料设计稳定,具有卓越的亮度、窄的激发和发射特性,可将溢出降至最低,并提高特定细胞群的分辨率,使研究人员能够制造更大、更好的面板。
Bio-Rad's StarBright Dyes complement Cytek's cFluor family of proprietary dyes, providing a wider variety of color options for highly multiplexed panel design and application development. Cytek plans to develop and optimize single vial reagents and multicolor panels using StarBright Dyes for the more than 1,500 Cytek Full Spectrum Profiling (FSP) instruments already deployed across more than 40 countries.
Bio-Rad的Starbright染料补充了Cytek的cFluor专利染料系列,为高度多元化的面板设计和应用开发提供了更广泛的颜色选择。Cytek计划为已经部署在40多个国家和地区的1,500多台Cytek全光谱分析(FSP)仪器开发和优化使用星光染料的单小瓶试剂和多色面板。
"Our focus has always been to provide a complete cell analysis solution to our customers, and the addition of Bio-Rad StarBright Dyes to our FSP platform is a big win for researchers conducting multiparameter experiments," noted Wenbin Jiang, CEO of Cytek Biosciences. "Researchers will be able to expand multiparameter analysis into violet and UV channels with Cytek-optimized reagents, unleashing the full power of FSP technology to obtain better resolution and a deeper understanding of populations."
Cytek Biosciences首席执行官蒋文斌指出:“我们的重点一直是为客户提供完整的细胞分析解决方案,而Bio-Rad Starbright Dyes加入我们的FSP平台对于进行多参数实验的研究人员来说是一个巨大的胜利。”研究人员将能够利用Cytek优化的试剂将多参数分析扩展到紫色和UV通道,充分释放FSP技术的力量,以获得更好的分辨率和对种群的更深入了解。
Bio-Rad StarBright Dye conjugates can also be integrated seamlessly into Cytek immunoprofiling assays. These easy-to-use, pre-optimized panels are designed by Cytek's scientists, freeing researchers from time-consuming, labor-intensive and costly panel design and optimization.
Bio-Rad Starbright Dye结合物还可以无缝集成到Cytek免疫图谱分析中。这些易于使用、预先优化的面板是由Cytek的科学家设计的,将研究人员从耗时、劳动密集型和昂贵的面板设计和优化中解放出来。
"Cytek has made a name for itself as a pioneer that has shifted the conventional dynamics surrounding flow cytometry, making our unique new reagents a perfect fit for their instruments," said Hilary Latham, marketing director for Bio-Rad. "We are proud to team with Cytek to bring more high-quality reagent choices on both violet and UV channels to researchers."
为Bio-Rad营销董事的希拉里·莱瑟姆说:“Cytek是改变了传统流式细胞术的先驱,我们独特的新试剂非常适合他们的仪器。”我们很自豪能与赛特克公司合作,为研究人员带来更多紫色和紫外线通道的高质量试剂选择。“
For more information about Cytek's cFluor reagents and kits, please visit
有关Cytek的cFluor试剂和试剂盒的更多信息,请访问
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧